Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
|Articles|March 15, 2011
Career Expo 2011 contacts
For Sponsorship questions: Jules LeoJules.Leo@ubm.com 201-984-6267Cindy FlaumCindy.Flaum@ubm.com 201-984-6266Help with registration:showsupport@ubm.com
Advertisement
For Sponsorship questions: Jules Leo
201-984-6267
Cindy FlaumCindy.Flaum@ubm.com
201-984-6266
Help with registration:showsupport@ubm.com
Advertisement
Related to this article
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.
Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.
Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.
Overlooking how hearing loss and sign language shape the Mental Status Examination can make language deprivation look like psychosis, authors warn.
Advertisement
Advertisement
Trending on Psychiatric Times
1
ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials
2
From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry
3
Hippocampal Generative Processes During Sleep Support Rapid Learning of New Associations
4
Post Hoc SOLARIS Data Support Stabilization and Remission With Subcutaneous Olanzapine
5